| 教員紹介トップページへ | 三重大学トップページへ |
| 職名 | 講師 | |||||||||
| 氏名 | あさぬま くにひろ 淺沼 邦洋 |
|||||||||
| 生年月 | 1972.06 | |||||||||
|
||||||||||
| TEL | ||||||||||
| FAX | ||||||||||
| kasanum@med. (末尾に mie-u.ac.jp を補ってください) | ||||||||||
| 個人のホームページ | ||||||||||
| 学歴 | 三重大学 学士課程 (～2003年03月31日) 満了
|
|||||||||
| 学位 | 2005.03 医学博士 三重大学
|
|||||||||
| 所属学会 | 日本整形外科学会 がん学会 中部整形外科災害外科学会 骨折治療学会 血栓止血学会 | |||||||||
| 社会活動 | ||||||||||
| 職歴 | 1998～ 三重大学 整形外科 医員
2007～ 三重大学医学部附属病院 集中治療部 助教 2010～ 三重大学医学部附属病院 整形外科 助教 2017～ 三重大学医学部附属病院 整形外科 講師 |
|||||||||
| 学術（芸術）賞 | ||||||||||
| 専門分野 | ||||||||||
| 現在の研究課題 | 骨軟部腫瘍ｂにおける免疫応答メカニズム 骨軟部腫瘍のバイオマーカー 肉腫の転移メカニズム | |||||||||
| 担当科目 | ||||||||||
| 主な業績等 | The adverse effect of an unplanned surgical excision of foot soft tissue sarcoma. 共著 2011 World journal of surgical oncology 9 160-
A novel hyperthermia treatment for bone metastases using magnetic materials. 共著 2011.04 International journal of clinical oncology 16 101-8 Recurrent hemarthrosis after unicompartmental knee arthroplasty. 共著 2011.09 Orthopedics 34 e578-80 Acridine orange inhibits pulmonary metastasis of mouse osteosarcoma. 共著 2011.12 Anticancer research 31 4163-8 Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases. 共著 2011.12 Clinical & experimental metastasis 28 819-25 The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis. 共著 2011.12 Journal of surgical oncology 104 771-5 Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. 共著 2012.02 Cancer 118 1055-61 Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus. 共著 2012.09 International journal of oncology 41 893-902 The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone. 共著 2013.07 Breast cancer (Tokyo, Japan) 20 241-6 Deep-vein thrombosis after resection of musculoskeletal tumours of the lower limb. 共著 2013.09 The bone & joint journal 95-B 1280-4 The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery. 共著 2013.10 Clinica chimica acta; international journal of clinical chemistry 425 109-13 The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. 共著 2013.12 Journal of surgical oncology 108 481-5 Role of high-sensitivity C-reactive protein in the differentiation of benign and malignant soft tissue tumors. 共著 2014.02 Anticancer research 34 933-6 Osteoporosis, vertebral fractures and mortality in a Japanese rural community. 共著 2014.09 Modern rheumatology / the Japan Rheumatism Association 24 840-3 Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. 共著 2014.10 International journal of clinical oncology 19 955-62 Extradural cryptococcoma at the sacral spine without bone involvement in an immunocompetent patient. 共著 2014.11 Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 19 1040-5 The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. 2015.06 The bone & joint journal 97-B 847-52 Treatment of the benign bone tumors including femoral neck lesion using compression hip screw and synthetic bone graft. 2015.06 SICOT-J 1 15- Clinical characteristics of patients with large and deep soft tissue sarcomas. 2015.08 Oncology letters 10 841-844 The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma. 2015.09 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 36 7515-20 Impact of plasma fibrinogen levels in benign and malignant soft tissue tumors. 2016 Cancer biomarkers : section A of Disease markers 16 453-8 Treatment of bone defect with calcium phosphate cement subsequent to tumor curettage in pediatric patients. 2016.01 Oncology letters 11 247-252 Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors. 2016.05 Cellular and molecular biology (Noisy-le-Grand, France) 62 27-32 Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux. 2016.05 International journal of hematology 103 554-9 Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery. 2016.05 International journal of hematology 103 560-6 Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement. 2016.08 World journal of surgical oncology 14 214- Neoplastic fever in patients with bone and soft tissue sarcoma. 2016.11 Molecular and clinical oncology 5 631-634 STAT3 inhibitor, cucurbitacinﾂI, is a novel therapeutic agent for osteosarcoma. 2016.12 International journal of oncology 49 2275-2284 Analysis of pulmonary nodules in patients with high-grade soft tissue sarcomas. 2017 PloS one 12 e0172148- Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung. 2017 OncoTargets and therapy 10 559-564 Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma. 2017 PloS one 12 e0181787- The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas. 2017.08 Scientific reports 7 9640- Subungual onychomycosis due to Aspergillus niger mimicking a glomus tumor: A case report. 2017.12 Biomedical reports 7 532-534 Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma. 2018 OncoTargets and therapy 11 6879-6886 Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2. 2018.03 Thrombosis research 163 30-40 Do exercise habits during middle age affect locomotive syndrome in old age? 2018.03 Modern rheumatology 28 334-338 Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma? 2018.06 Anticancer research 38 3635-3639 Long-term clinical outcome in patients with high-grade soft tissue sarcoma who were treated with surgical adjuvant therapy using acridine orange after intra-lesional or marginal resection. 2018.09 Photodiagnosis and photodynamic therapy 23 165-170 Intra-articular synovial sarcoma in the ankle joint: A case report. 2018.10 Molecular and clinical oncology 9 464-466 Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas. 2019 Cancer biomarkers : section A of Disease markers 26 163-170 Successful treatment with cryoablation in a patient with bone metastasis in the mid-shaft femur: a case report. 2019 OncoTargets and therapy 12 2949-2953 The clinical outcomes of total femur prosthesis in patients with musculoskeletal tumors. 2019 SICOT-J 5 23- Tumor Resection May Improve Survival in Patients With Soft Tissue Sarcoma Aged 75 Years and Older. 2019.01 Anticancer research 39 331-334 Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma. 2019.04 Oncology letters 17 3937-3943 Soft tissue sarcoma at the adductor compartment of the thigh may have a greater risk of tumor-associated events and wound complications. 2019.05 Journal of orthopaedic surgery (Hong Kong) 27 2309499019840813- The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study. 2019.08 Clinical & experimental metastasis 36 343-350 The Clinical Outcomes of Hemicortical Extracorporeal Irradiated Autologous Bone Graft After Tumor Resection of Bone and Soft Tissue Sarcoma. 2019.10 Anticancer research 39 5605-5610 Is Serum Lactate Dehydrogenase Useful for Predicting Oncological Outcome in Patients With Soft Tissue Sarcoma? 2019.12 Anticancer research 39 6871-6875 Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan. 2020 Drug design, development and therapy 14 4215-4220 Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group. 2020 Cancer management and research 12 10017-10022 Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas. 2020.03 Cancers 12 Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas. 2020.06 Scientific reports 10 9077- Osteoconductivity of bioactive Ti-6Al-4V implants with lattice-shaped interconnected large pores fabricated by electron beam melting. 2020.10 Journal of biomaterials applications 885328220968218- Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10窶謁ears. 2020.10 Orthopaedic surgery Anti-tumour effect of tocilizumab for osteosarcoma cell lines. 2020.11 Bone & joint research 9 821-826 Cases of abdominal wall endometriosis distinguished from soft tissue tumors: A report of three cases. 2020.12 Biomedical reports 13 64- Clinical outcome of latissimus dorsi reconstruction after wide resection of soft-tissue sarcoma. 2020.12 European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 30 1441-1446 Deep vein thrombosis of the upper extremity caused by central venous port in a patient with soft tissue sarcoma: A case report. 2020.12 Molecular and clinical oncology 13 89- |
|||||||||